Vnitr Lek 2017, 63(7-8):535-539 | DOI: 10.36290/vnl.2017.109

Heart transplantation and infection

Eva Ozábalová1,*, Jan Krejčí1, Petr Hude1, Julius Godava1, Tomáš Honek1, Lenka Špinarová1, Petr Pavlík2, Helena Bedáňová2, Petr Němec2
1 I. interní kardio-angiologická klinika LF MU a FN u sv. Anny v Brně
2 Centrum kardiovaskulární a transplantační chirurgie, Brno

Heart transplantation (HTx) is a method of treatment for patients with end-stage heart failure with severe symptoms despite complex therapy. Post-transplant difficulties include acute rejection and infectious complications, which are the most common reason of morbidity and mortality in the first year after heart transplant. It requires the patient to remain on immunosuppressive medication to avoid the possibility of graft rejection. Therefore the range of infection is much larger. The diagnosis and treatment of viral, bacterial and fungal infections is often difficult.

Keywords: heart transplantation; immunosuppression; infection

Received: May 22, 2017; Accepted: June 20, 2017; Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ozábalová E, Krejčí J, Hude P, Godava J, Honek T, Špinarová L, et al.. Heart transplantation and infection. Vnitr Lek. 2017;63(7-8):535-539. doi: 10.36290/vnl.2017.109.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lund LH, Edwards LB, Dipchand AI et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation: Report - 2016; Focus Theme: Primary Diagnostic Indications for Transplant. J Heart Lung Transplant 2016; 35(10): 1158-1169. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2016.08.017>. Go to original source... Go to PubMed...
    2. Delgado JF, Sánchez V, de la Calzada CS. Acute rejection after heart transplantation. Expert Opin Pharmacother 2006; 7(9): 1139-1149. Dostupné z DOI: <http://dx.doi.org/10.1517/14656566.7.9.1139>. Go to original source... Go to PubMed...
    3. Gurguí M, Muňoz P. Infection in heart transplantation. Enferm Infecc Microbiol Clin 2007; 25(9): 587-597. Go to original source... Go to PubMed...
    4. Montoya JG, Giraldo LF, Efron B et al. Infectious complications among 620 consecutive heart transplant patients at Standford University Medical Center. Clin Infect Dis 2001; 33(5): 629-640. Go to original source... Go to PubMed...
    5. Fishman JA. Infection in solid-organ transplant recipient. NEJM 2007; 357(25): 2601-2614. Go to original source... Go to PubMed...
    6. Sanchez-Lazaro IJ, Almenar L, Blanes M et al. Timing, etiology and location of first infection in first year after heart transplantation. Transplant Proc 2010; 42(8): 3017-3019. Dostupné z DOI: <http://dx.doi.org/10.1016/j.transproceed.2010.07.052>. Go to original source... Go to PubMed...
    7. Melero-Ferrer J, Sanchez-Lazaro IJ, Navea-Tejerina A et al. Repeated CMV Infection in a Heart Transplantation Patient. Case Rep Transplant 2012; 2012: 305920. Dostupné z DOI: <http://dx.doi.org/10.1155/2012/305920>. Go to original source... Go to PubMed...
    8. Doesch AO. Infections after Heart Transplantation. Transplantationsmedizin 2011; 23: 115-117. Dostupné z WWW: http://www.transplantation.de/fileadmin/transplantation/txmedizin/txmedizin_2011_2/05_doesch.pdf>.
    9. Johansonn I, Andersson R, Friman V et al. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients. BMC Infect Dis 2015; 15: 582. Dostupné z DOI: <http://dx.doi.org/10.1186/s12879-015-1321-1>. Go to original source... Go to PubMed...
    10. Hummel M. Early postoperative therapy after heart transplantation: Prophylaxis, diagnosis and antibiotic, antimycotic and antiviral therapy of infections. ACP 2011; 15: 245-255. Dostupné z WWW: <http://www.applied-cardiopulmonary-pathophysiology.com/fileadmin/downloads/acp-2011-4_20111229/09_hummel.pdf>.
    11. Hodson EM, Jones CA, Webster AC et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systemic review of randomised controlled trials. Lancet 2005; 365(9477): 2105-2115. Go to original source... Go to PubMed...
    12. Muñoz P, Rodríguez C, Bouza E et al. Risk Factors of Invasive Aspergillosis after Heart Transplantation:Protective Role of Oral Itraconazole Prophylaxis. Am J of Transpl 2004; 4(4): 636-643. Go to original source... Go to PubMed...
    13. Hajjeh RA, Warnock DW. Counterpoint: invasive aspergillosis and the environment - rethinking our approach to prevention. Clin Infect Dis 2001; 33(9): 1549-1552. Go to original source... Go to PubMed...
    14. Gustafson TL, Schaffner W, Lavely G et al. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983; 148(2): 230-238. Go to original source... Go to PubMed...
    15. Ráčil Z, Mayer J, Cetkovský P et al. Invazivní aspergilóza: současné možnosti diagnostiky. Vnitř Lék 2007; 53(Suppl): S1-S34.
    16. Taccone FS, Van Den Abeele AM, Bulpa P et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcome. Crit Care 2015; 19: 7. Dostupné z DOI: <http://dx.doi.org/10.1186/s13054-014-0722-7>. Go to original source... Go to PubMed...
    17. Musher B, Fredricks D, Leisenring W et al. Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid. J Clin Microbiol 2004; 42(12): 5517-5522. Go to original source... Go to PubMed...
    18. Ráčil Z, Mayer J, Kocmanová I et al. Léčba invazivní aspergilózy - doporučení odborných společností. Vnitř Lék 2008; 54(12): 1187-1194. Go to PubMed...
    19. Denning DW. Therapeutic Outcome in Invasive Aspergillosis. Clin Infect Dis 1996; 23(3): 608-615. Go to original source... Go to PubMed...
    20. Preiksaitis JK, Green M, Avery RK et al. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 2004; 4(Suppl 10): S5-S166.
    21. Pazdernik M, Malek I, Koudelkova E et al. Bone marrow suppression and associated consequences in patients after heart transplantation: A 6-year retrospective review. Biomed Pap Med Fac Univ Palacky Olomouc 2015; 159(3): 372-377. Dostupné z DOI: <http://dx.doi.org/10.5507/bp.2015.022>. Go to original source... Go to PubMed...
    22. Kotton CN, Kumar D, Caliendo AM et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89(7): 779-795. Dostupné z DOI: <http://dx.doi.org/10.1097/TP.0b013e3181cee42f>. Go to original source... Go to PubMed...
    23. Costanzo MR, Dipchand A, Starling R et al. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29(8): 914-956. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2010.05.034>. Go to original source... Go to PubMed...
    24. Muňoz P, Crespo Leiro MG. Prophylaxis of cytomegalovirus infection in heart transplantation. Enferm Infecc Microbiol Clin 2011; 29(Suppl 6): S52-S55. Dostupné z DOI: <http://dx.doi.org/10.1016/S0213-005X(11)70059-3>. Go to original source... Go to PubMed...
    25. Sun HY, Wagener M, Singh N. Prevention of posttransplant cytomegalovirus dinase and related outcomes with valganciclovir: a systemic review. Am J of Transpl 2008; 8(10): 2111-2118. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1600-6143.2008.02369.x>. Go to original source... Go to PubMed...
    26. Kalil AC, Levitsky J, Lyden E et al. Metaanalysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005; 143(12): 870-880. Go to original source... Go to PubMed...
    27. Cahil BC, Hibbs JR, Savik K et al. Aspergillus Airway Colonization and Invasive Disease After Lung Transplantation. Chest 1997; 112(5): 1160-1164. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.